What are the alternative antibiotics for Group B strep (Group B streptococcus) prophylaxis in patients allergic to penicillin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Antibiotics for Group B Streptococcus in Penicillin-Allergic Patients

For patients allergic to penicillin, the recommended alternative antibiotics for Group B streptococcus (GBS) prophylaxis depend on the severity of the allergic reaction, with cefazolin being preferred for non-severe allergies and vancomycin or clindamycin (if susceptible) for severe allergies. 1

Assessment of Penicillin Allergy Severity

  • Determine if the patient has a high risk for anaphylaxis, defined as a history of anaphylaxis, angioedema, respiratory distress, or urticaria following administration of penicillin or cephalosporin 1
  • For patients without these severe reactions, cefazolin is the recommended alternative, as true penicillin allergy occurs in a smaller percentage of patients than reported 2, 3
  • Approximately 10% of persons with penicillin allergy have cross-reactivity with cephalosporins, making allergy history verification important 3

Treatment Algorithm Based on Allergy Severity

For Non-Severe Penicillin Allergy:

  • Cefazolin: 2g IV initial dose, then 1g IV every 8 hours until delivery 1
  • Cefazolin is preferred because pharmacologic data suggest it achieves effective intraamniotic concentrations 1
  • GBS isolates remain highly susceptible to cefazolin, with minimum inhibitory concentrations consistently low 3, 4

For Severe Penicillin Allergy (history of anaphylaxis, angioedema, respiratory distress, or urticaria):

  • Obtain antimicrobial susceptibility testing for clindamycin and erythromycin if possible 1
  • If the isolate is susceptible to clindamycin:
    • Clindamycin: 900 mg IV every 8 hours until delivery 1
  • If susceptibility testing is not performed, results are not available, or isolate is resistant:
    • Vancomycin: 1g IV every 12 hours until delivery 1

Important Considerations

  • Resistance to erythromycin (21%) is more common than resistance to clindamycin (4%), making clindamycin generally preferred when susceptible 4
  • If an isolate is resistant to erythromycin but susceptible to clindamycin, testing for inducible clindamycin resistance should be performed 1
  • Erythromycin is no longer recommended for GBS infections due to increasing resistance 2, 5
  • All GBS isolates remain susceptible to penicillin worldwide, making it the first choice when not contraindicated 2
  • Vancomycin should be reserved for cases where no other options exist, due to concerns about promoting antimicrobial resistance 3

Clinical Pearls and Pitfalls

  • Always obtain susceptibility testing when treating GBS infections in penicillin-allergic patients 2, 3
  • The CDC recommends against using cefazolin in patients with severe penicillin allergy due to risk of cross-reactivity 2
  • Consider penicillin allergy testing during pregnancy, as confirmation or delabeling from a penicillin allergy can provide both short- and long-term health benefits 6
  • A recent study found that antibiotic susceptibility testing was performed on GBS isolates in only 74.2% of penicillin-allergic patients, indicating room for improvement in following guidelines 7
  • Intrapartum antibiotic prophylaxis is optimal if administered for at least 4 hours before delivery 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Group B Strep UTI in Patients with Severe Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternative Antibiotics for Group B Streptococcus (GBS) Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic Prescribing Practices in Group B Streptococcus Positive Obstetric Patients with Penicillin Allergy.

South Dakota medicine : the journal of the South Dakota State Medical Association, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.